RenalBehavioral conditioning prolongs heart allograft survival in rats☆
Section snippets
Materials and methods
We established a conditioning model in rats using saccharin as the CS and intraperitoneally (IP) administered cyclosporine A (20 mg/kg; CsA) as the UCS (conditioned rats).2, 3 Control animals were given water paired with CsA on training days (sham conditioned rats). Male Dark Agouti (DA; RT1a) rats underwent a three learning trial paradigm (CS–UCS pairing). Subsequently, animals were daily re-presented with the CS only. On the CS re-presentation days, conditioned rats received saccharin, with
Results
Behaviorally conditioned rats demonstrated a significant prolongation of heart allograft survival in comparison to sham conditioned animals (Table 1). Furthermore, the conditioned effect paralleled that produced by 3 days of CsA treatment.
Discussion
These results suggest that the conditioned immunosuppression produced by CsA2, 3 can significantly prolong the survival time of a heterotopic heart allograft in DA rats. Furthermore, such treatment mimics the effectiveness of a short term CsA regimen.
References (4)
- et al.
Physiol Behav
(1998) - et al.
J Thorac Cardiovasc Surg
(1969)
Cited by (26)
Placebo Effects in the Immune System
2018, International Review of NeurobiologyApplications and limitations of behaviorally conditioned immunopharmacological responses
2017, Neurobiology of Learning and MemoryCitation Excerpt :However, in contrast, US or CS pre-exposure did not affect the conditioned suppression of interleukin (IL)-2 production (Lueckemann et al., 2016). These results support earlier observations, showing that re-exposure to the taste, but not a significant taste avoidance is essential for a conditioned immunosuppression indicated by weak or even absent correlations between the CTA and the learned immunosuppressive response (Ader & Cohen, 1982; Bovbjerg, Ader, & Cohen, 1984; Bovbjerg, Kim, Siskind, & Weksler, 1987; Exton et al., 1998; Schedlowski & Pacheco-Lopez, 2010). From the clinical perspective, these findings are also of interest since they suggest that patients who already are on immunosuppressive therapy with CaN inhibitors such as CsA could still develop a learned immunosuppression.
Repeated recall of learned immunosuppression: Evidence from rats and men
2011, Brain, Behavior, and ImmunityCitation Excerpt :Additionally, we did not find any differences in cytokine production between placebo and experimental groups before evocation, which is arguing against a residual or delayed CsA effect that may account for the observed immunosuppression. The conditioned suppression of T cell function was neither associated with changes in plasma levels of cortisol or catecholamines nor with changes in blood T cell numbers, confirming earlier observations in humans and rodents (Exton et al., 1998a,b; Goebel et al., 2002; Niemi et al., 2007; Pacheco-Lopez et al., 2009; Roudebush and Bryant, 1991). Previous experiments in rodents demonstrated that the learning and memory processes of behaviorally conditioned immunosuppression in a CsA-taste avoidance paradigm are centrally mediated, via the amygdala and the insular cortex (Pacheco-Lopez et al., 2005).
The learned immune response: Pavlov and beyond
2010, Brain, Behavior, and ImmunityCitation Excerpt :Behaviorally conditioned CsA-immunosuppressive effects prolonged the survival time of heterotopically transplanted heart allografts in rats (Grochowicz et al., 1991). In follow-up experiments, this conditioned prolongation of heart allograft survival could be confirmed employing a similar conditioning paradigm (Exton et al., 1998a). Moreover, a combination of the conditioning procedure with a treatment of sub-therapeutical doses of the immunosuppressive drug CsA and daily re-exposure to the CS lead to long-term survival (>100 days) of transplants in 20–30% of the animals in two independent experiments, and these effects were completely antagonized by prior surgical denervation of the spleen (Exton et al., 1999).
Behavioral conditioning of the immune system
2002, International Review of NeurobiologyConditioning of the immune system—Already clinically usable?
2023, Zeitschrift fur Rheumatologie
- ☆
This work was supported by a grant from the VW foundation (I/70 485).